Article Information
History
- October 29, 2024.
Article Versions
- Version 1 (June 13, 2023 - 10:18).
- Version 2 (June 27, 2023 - 08:19).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Arielle Klepper1,8,
- James Asaki2,9,
- Andrew F. Kung2,
- Sara E. Vazquez3,
- Aaron Bodansky4,
- Anthea Mitchell5,
- Sabrina A. Mann2,5,
- Kelsey Zorn2,
- Isaac Avila-Vargas1,
- Swathi Kari1,
- Melawit Tekeste1,
- Javier Castro1,
- Briton Lee1,
- Maria Duarte1,8,
- Mandana Khalili1,8,
- Monica Yang1,
- Paul Wolters1,
- Jennifer Price1,8,
- Emily Perito4,8,
- Sandy Feng6,8,
- Jacquelyn J. Maher1,8,
- Jennifer C. Lai1,8,
- Christina Weiler-Normann7,
- Ansgar W. Lohse7,
- Joseph DeRisi2,5,*,# and
- Michele Tana1,8,*
- 1Department of Medicine, University of California, San Francisco, USA
- 2Department of Biochemistry, University of California, San Francisco, USA
- 3Department of Dermatology, Mass General Hospital, Boston, MA
- 4Department of Pediatrics, University of California, San Francisco, USA
- 5Chan Zuckerberg Biohub; San Francisco, CA, USA
- 6Department of Surgery, University of California, San Francisco, USA
- 7Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 8UCSF Liver Center
- 9Gladstone-UCSF Institute of Genomic Immunology, San Francisco, USA
- ↵#Corresponding author; email: joe{at}derisilab.ucsf.edu
↵* Authors contributed equally to this work
Posted October 29, 2024.
Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights
